CDKN1A and cancer: Epigenetic silencing of CDKN1A gene expression in cancer cells by histone modification and promoter DNA methylation is suggested by the upregulation of CDKN1A gene expression after treatment with the HDAC inhibitor trichostatin A (TSA) or the DNA methylation inhibitor 5-aza-2'-deoxycytidine (31).